Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenetics of Efavirenz Metabolism: Association of CYP2B6 Genotype and Prolonged Drug Exposure

NCT00245986 is registered in ClinicalTrials.gov with National Institutes of Health Clinical Center (CC) as lead sponsor.

NCT NCT00245986
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00245986 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenetics of Efavirenz Metabolism: Association of CYP2B6 Genotype and Prolonged Drug Exposure
Lead sponsor
National Institutes of Health Clinical Center (CC)
Phase
Phase 4
Overall status
Completed
Start date
October 18, 2005
Completion date
May 20, 2008
Enrollment
350
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolism